VPS52
Basic information
Region (hg38): 6:33250272-33272047
Previous symbols: [ "SACM2L" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the VPS52 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 2 | |||||
missense | 36 | 36 | ||||
nonsense | 1 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 1 | |||||
Total | 0 | 0 | 37 | 0 | 3 |
Variants in VPS52
This is a list of pathogenic ClinVar variants found in the VPS52 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
6-33250929-G-A | not specified | Uncertain significance (Dec 16, 2023) | ||
6-33251615-C-T | not specified | Uncertain significance (Feb 28, 2023) | ||
6-33251892-C-T | not specified | Uncertain significance (Dec 09, 2023) | ||
6-33263846-C-T | not specified | Uncertain significance (Aug 12, 2022) | ||
6-33264061-T-C | not specified | Uncertain significance (Sep 27, 2022) | ||
6-33264073-C-T | not specified | Uncertain significance (Dec 21, 2022) | ||
6-33264102-A-C | not specified | Uncertain significance (Feb 06, 2024) | ||
6-33264399-C-A | not specified | Uncertain significance (May 26, 2022) | ||
6-33264472-G-C | not specified | Uncertain significance (Jul 14, 2022) | ||
6-33264791-G-A | not specified | Uncertain significance (Nov 09, 2021) | ||
6-33264879-C-T | not specified | Uncertain significance (Sep 27, 2022) | ||
6-33264910-T-A | Benign (Apr 10, 2018) | |||
6-33266561-G-A | not specified | Uncertain significance (May 30, 2024) | ||
6-33266641-G-T | not specified | Uncertain significance (Oct 06, 2021) | ||
6-33266665-G-A | Benign (Apr 10, 2018) | |||
6-33266672-A-G | not specified | Uncertain significance (Sep 12, 2023) | ||
6-33266677-G-A | Benign (Jun 06, 2017) | |||
6-33267243-G-C | not specified | Uncertain significance (Feb 07, 2023) | ||
6-33267268-T-C | not specified | Uncertain significance (Nov 21, 2022) | ||
6-33267289-T-C | not specified | Uncertain significance (Jun 17, 2024) | ||
6-33267871-C-G | not specified | Uncertain significance (Dec 14, 2022) | ||
6-33267874-C-T | not specified | Uncertain significance (Jan 04, 2022) | ||
6-33267881-C-T | not specified | Uncertain significance (May 24, 2023) | ||
6-33267986-T-C | not specified | Uncertain significance (Oct 12, 2021) | ||
6-33268139-G-C | not specified | Uncertain significance (Apr 03, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
VPS52 | protein_coding | protein_coding | ENST00000445902 | 20 | 21776 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.000389 | 1.00 | 125708 | 0 | 40 | 125748 | 0.000159 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.50 | 286 | 432 | 0.662 | 0.0000264 | 4671 |
Missense in Polyphen | 81 | 139.29 | 0.58152 | 1526 | ||
Synonymous | 1.60 | 134 | 160 | 0.839 | 0.00000854 | 1461 |
Loss of Function | 4.30 | 15 | 46.7 | 0.321 | 0.00000292 | 461 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000481 | 0.000460 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000109 | 0.000109 |
Finnish | 0.000370 | 0.000370 |
European (Non-Finnish) | 0.000135 | 0.000132 |
Middle Eastern | 0.000109 | 0.000109 |
South Asian | 0.000367 | 0.000229 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Acts as component of the GARP complex that is involved in retrograde transport from early and late endosomes to the trans-Golgi network (TGN). The GARP complex is required for the maintenance of the cycling of mannose 6-phosphate receptors between the TGN and endosomes, this cycling is necessary for proper lysosomal sorting of acid hydrolases such as CTSD (PubMed:15878329, PubMed:18367545). Acts as component of the EARP complex that is involved in endocytic recycling. The EARP complex associates with Rab4-positive endosomes and promotes recycling of internalized transferrin receptor (TFRC) to the plasma membrane (PubMed:25799061). {ECO:0000269|PubMed:15878329, ECO:0000269|PubMed:18367545, ECO:0000269|PubMed:25799061}.;
- Pathway
- Vesicle-mediated transport;Membrane Trafficking;Retrograde transport at the Trans-Golgi-Network;Intra-Golgi and retrograde Golgi-to-ER traffic
(Consensus)
Intolerance Scores
- loftool
- 0.241
- rvis_EVS
- -0.51
- rvis_percentile_EVS
- 21.56
Haploinsufficiency Scores
- pHI
- 0.300
- hipred
- Y
- hipred_score
- 0.627
- ghis
- 0.543
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.961
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Vps52
- Phenotype
- growth/size/body region phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); normal phenotype; embryo phenotype;
Gene ontology
- Biological process
- Golgi to vacuole transport;lysosomal transport;ectodermal cell differentiation;protein transport;endocytic recycling;retrograde transport, endosome to Golgi;embryonic ectodermal digestive tract development
- Cellular component
- GARP complex;Golgi apparatus;cytosol;endosome membrane;membrane;trans-Golgi network membrane;perinuclear region of cytoplasm;recycling endosome;EARP complex
- Molecular function
- protein binding;Rab GTPase binding;syntaxin binding